Flumazenil reversal of midazolam in dogs: dose-related changes in cerebral blood flow, metabolism, EEG, and CSF pressure
- PMID: 15815239
Flumazenil reversal of midazolam in dogs: dose-related changes in cerebral blood flow, metabolism, EEG, and CSF pressure
Abstract
Large doses of flumazenil, given rapidly (over 5-10 s), are reported to elevate cerebral blood flow (CBF) and intracranial pressure to supranormal values when given to dogs receiving midazolam. This study examined the cerebral effects of giving smaller, graduated doses of flumazenil (0.0025, 0.01, 0.04, and 0.16 mg/kg), slowly (over 60 s), to dogs receiving midazolam and to dogs not receiving midazolam both when cerebrospinal fluid (CSF) pressure was normal and when CSF pressure was elevated (intracranial balloon) to about 30 mm Hg. In dogs with normal CSF pressure that were receiving midazolam, the effects of flumazenil were as follows: (a) low doses of flumazenil caused reversal of the reduction in cerebral metabolic rate for oxygen (CMRO2) and activity of the electroencephalogram produced by midazolam, (b) moderate doses of flumazenil produced a decrease of cerebral vascular resistance, and an increase of CBF and CSF pressure that did not significantly change cerebral perfusion pressure (CPP), and (c) the highest dose of flumazenil increased CBF to supranormal values. All of these flumazenil effects "peaked" at 3-6 min, with values returning to pre-flumazenil levels by 15-30 min. Flumazenil caused no such changes in dogs with elevated CSF pressure that were receiving midazolam or in dogs that were not receiving midazolam. The results are consistent with a specific, doserelated benzodiazepineantagonist action of flumazenil. Lack of flumazenil effect at elevated CSF pressure may reflect reversible changes in cerebral structure, metabolism, or benzodiazepine receptors produced by the intracranial balloon and elevation of CSF pressure. The doses of flumazenil used here to reverse the cerebral effects of midazolam appear unlikely to produce adverse effects because increase of CMRO2 was matched by increase of CBF, the mean increase of CSF pressure was modest (+9 +/- 3 mm Hg, mean +/- SEM), and CPP was unchanged.
Similar articles
-
Flumazenil does not impair autoregulation of CBF in dogs when given with or without prior administration of midazolam.J Neurosurg Anesthesiol. 1989 Sep;1(3):241-8. doi: 10.1097/00008506-198909000-00006. J Neurosurg Anesthesiol. 1989. PMID: 15815280
-
[Effect of flumazenil on global cerebral blood flow and on intracranial pressure in the reperfusion phase following incomplete global cerebral ischemia].Anasth Intensivther Notfallmed. 1988 Jun;23(3):159-62. Anasth Intensivther Notfallmed. 1988. PMID: 3135764 German.
-
The rate of CSF formation, resistance to reabsorption of CSF, and aperiodic analysis of the EEG following administration of flumazenil to dogs.Anesthesiology. 1990 Jan;72(1):111-7. doi: 10.1097/00000542-199001000-00020. Anesthesiology. 1990. PMID: 2105064
-
Midazolam and flumazenil in neuroanaesthesia.Acta Anaesthesiol Scand Suppl. 1990;92:96-102. doi: 10.1111/j.1399-6576.1990.tb03194.x. Acta Anaesthesiol Scand Suppl. 1990. PMID: 2109478 Review.
-
[Hierarchical strategy for treating elevated intracranial pressure in severe traumatic brain injury].Ann Fr Anesth Reanim. 2007 May;26(5):440-4. doi: 10.1016/j.annfar.2007.03.001. Epub 2007 Apr 16. Ann Fr Anesth Reanim. 2007. PMID: 17434712 Review. French.
Cited by
-
Changing practices in neuroanaesthesia.Can J Anaesth. 1990 May;37(4 Pt 2):Slxxxix-Scvii. doi: 10.1007/BF03006278. Can J Anaesth. 1990. PMID: 2193724 Review. English, French. No abstract available.
-
Intraocular pressure in anaesthetized dogs given flumazenil with and without prior administration of midazolam.Can J Anaesth. 1991 Apr;38(3):408-14. doi: 10.1007/BF03007632. Can J Anaesth. 1991. PMID: 2036701
LinkOut - more resources
Full Text Sources